Long-term safety of optogenetic gene delivery and light exposure

Determine the long-term effects on neurons of retroviral vector-mediated genome insertion, expression of non-human opsin proteins, and prolonged optical exposure used in optogenetic neuromodulation, in order to establish the safety and stability required for translation to human applications.

Background

Optogenetics enables cell-type-specific neural stimulation with millisecond precision and has transformed basic neuroscience. However, translation to clinical use requires introducing genes that encode light-sensitive ion channels (opsins) into human neurons, typically via viral vectors, and delivering light repeatedly over long periods.

The paper emphasizes that, despite powerful advantages, critical safety aspects remain unresolved: the consequences of retroviral genome insertion, expressing non-human opsins in neurons, and chronic light exposure have not been established. These unknowns are central barriers to demonstrating that gene delivery methods for optogenetics are safe and stable in the long term, which is necessary for human application.